All filters
Videos
Exploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE Study - Margaret Gartland
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
HIV-1Reverse Transcriptase Natural Polymorphism V106I Does Not Alter the Susceptibility and the Genetic Barrier to Resistance to Doravirine in Vitro - Federica Giammarino, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Kinetics of Archived M184V Mutation in HIV-DNA from Highly Experienced HIV-Infected Patients with Sustained Viral Suppression - Romain Palich, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Low Prevalence of Archived M184V/I Mutations in 3 HIV-1 Suppressed, Switch Studies- Ruolan Wang
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
HIV-1 Subtypes B, G and CRF02_AG Transmission Cluster in Migrants Population Followed in Portugal Based on Sequence Data - Victor Pimentel
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
"Prevalence of genotypic baseline risk factors of cabotegravir+rilpivirine failure among ARV-naïve patients "- Charlotte Charpentier, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
LONG-ACTING HIV CAPSID INHIBITOR EFFECTIVE AS PREP IN A SHIV RHESUS MACAQUE MODEL- Elena Bekerman, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers - Stéphane Marot, MD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Molecular epidemiology of SARS-CoV-2 in Greece reveals low rates of onward virus transmission after lifting of travel restrictions based on risk assessment during summer 2020- Evangelia Georgia Kostaki, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Characterization of SARS-CoV-2 variants circulating in Central Italy by deep-sequencing of full-length S gene - Maria Bellocchi,
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Interaction Subtypes and New Drugs- Charlotte Charpentier, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
The Top 10 Important Observations of the Last Year Affecting Clinical Management - Valentina Svicher, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Impact on Diagnostics and Treatment- Francesca Ceccherini- Silberstein, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
The Future of HIV Prevention: Who, With What and for How Long? - Kenneth Mayer, MD
Presented at:
European HIV Clinical Forum 2021
Videos
Clinical Experience with Long-Acting PrEP: What Have We Learned? - Beatriz Grinsztejn, MD, PhD
Presented at:
European HIV Clinical Forum 2021
Videos
Prevention Trials in the Last Year: What Have We Learned? - Sheena McCormack, MD
Presented at:
European HIV Clinical Forum 2021
Videos
The Role of Clinical Pharmacology in Optimizing Treatment of HIV in Pregnancy and Breastfeeding - Catriona Waitt, MBChB, PhD
Presented at:
European HIV Clinical Forum 2021
Videos
Resistance Testing and Interpretation - Robert Shafer, MD
Presented at:
European HIV Clinical Forum 2021
Videos
Impact of Mental Health on Quality of Life - Carmina Fumaz, MSc, PhD
Presented at:
European HIV Clinical Forum 2021
Videos
Conception and Pregnancy - Sharon Walmsley, FRCPC, MD, MSC
Presented at:
European HIV Clinical Forum 2021
Videos
Avoiding and Minimizing Drug Toxicity - Laura Waters, MD, FRCP
Presented at:
European HIV Clinical Forum 2021